Why is Bliss GVS Pharma falling/rising?

As of 04-Sep, Bliss GVS Pharma Ltd is currently priced at 156.60, reflecting a decrease of 2.75, or 1.73%. The stock has underperformed its sector today by 1.2% and has experienced a trend reversal, falling after three consecutive days of gains. It reached an intraday low of Rs 156, indicating a decline of 2.1%. The stock's performance over the past week shows a decrease of 2.19%, and over the past month, it has dropped by 12.93%. Although the stock has generated a return of 22.49% over the past year, its profits have declined by 3.6%, and it is currently trading at a premium compared to its peers' average historical valuations. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 52.44% against the five-day average.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with the Sensex gaining 0.80% over the past week while Bliss GVS Pharma has declined. The stock's year-to-date performance is down 4.89%, contrasting with the Sensex's increase of 3.30%. Despite its long-term outperformance, including a 92.74% return over the past three years, the recent decline suggests that current market conditions and investor sentiment may be weighing heavily on the stock's price.